Advertisement
The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

Omnicare begins offer to buy $525M in debentures

November 17, 2010 5:46 pm | by The Associated Press | News | Comments

Omnicare Inc., which sells drugs to nursing homes and long-term care facilities, said Wednesday it began a tender offer for up to $525 million of its 3.25 percent convertible senior debentures due 2035.The company said the tender offer will expire Dec. 15. Debentures are used as a way for...

Tokyo Stock Exchange: morning price list -6-+

November 17, 2010 5:45 pm | by The Associated Press | News | Comments

TSEPrices UP/DN Nippon Meat Packers984 UP7 Nippon Paper Grp Inc 2021 UP 17 Nippon Sharyo Ltd368 UP5 Nippon Sheet Glass187 UP4 Nippon Shokubai Co784 UP1 Nippon Soda Co339 UP3 Nippon Steel Corp272 UP1 Nippon Suisan251 UP1 Nissan Chem Ind Ltd999 UP8 Nissan Motor Co787 DN7 Nisshin...

Summary Box: Medicare panel backs Provenge

November 17, 2010 1:45 pm | by The Associated Press | News | Comments

VOTE OF CONFIDENCE: Medicare advisers said they are confident in the benefits of Provenge, an innovative prostate cancer drug that has generated controversy because of its $93,000 price tag. Medicare will make a final decision on whether to pay for the drug in March.HURDLE CLEARED: The positive...

Advertisement

Medicare panel backs costly cancer drug Provenge

November 17, 2010 12:45 pm | by MATTHEW PERRONE - AP Health Writer - Associated Press | News | Comments

Medicare advisers on Wednesday supported the effectiveness of the prostate cancer drug Provenge, an innovative therapy that has prompted questions about the cost of medical care and the government's role in paying for it.The vote by a 14-member panel of outside experts amounts to a...

How Are You Influencing ER and Surgical Devices?

November 17, 2010 11:59 am | Articles | Comments

Newton Defaria, Business Development Manager for Life and Analytical Sciences, National Instruments: National Instruments has a comprehensive technological portfolio that is used in the design, development, deployment, manufacturing, and test of many devices involved in surgery.

Structure of Lassa virus protein reveals viral thievery

November 17, 2010 11:40 am | by EurekAlert | News | Comments

(Emory University) Scientists have solved the structure of a key protein from Lassa virus, which is endemic to West Africa and can cause a deadly hemorrhagic fever. The structure reveals how the virus evades its host's immune system, and how it hijacks infected cells' vital...

TOPICS:

HealthEdge Software rounds up $975K financing

November 17, 2010 11:39 am | by Mass High Tech: The Journal of New England Technology | News | Comments

HealthEdge Software Inc., a Burlington health-care software provider, has taken in $974,966 in a combination offering of equity and warrants, according to a filing with the U.S. Securities and Exchange Commission.

Forma collaborating with Eisai in $20M+ deal

November 17, 2010 11:38 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Cambridge small-molecule therapeutics developer Forma Therapeutics Inc. has signed a drug discovery collaboration agreement with Eisai Inc., the U.S. subsidiary of Tokyo pharmaceutical firm Eisai Co. Ltd.

Advertisement

Roundtable Q & A: Testing

November 17, 2010 10:51 am | by Jeffrey D. Lind, Brandon Tillman, Dave Kralovetz, and Lisa Olson | Nelson Laboratories, Inc., WuXi AppTec | Articles | Comments

Participants: Jeffrey D. Lind, President, Compliance West, USA; Brandon Tillman, Sales Manager, Nelson Laboratories; Dave Kralovetz, Medical Account Development Manager, Cincinnati Test Systems; Lisa Olson, Vice President of Testing and Service Development, WuXi AppTec

Mortal chemical combat typifies the world of bacteria

November 17, 2010 9:42 am | by EurekAlert | News | Comments

(University of North Carolina School of Medicine) New research led by scientists from the University of North Carolina at Chapel Hill School of Medicine and the University of California, Santa Barbara, describes new complexities in the close chemical combat waged among bacteria....

TOPICS:

AesRx gets NIH boost for sickle cell treatment

November 17, 2010 9:41 am | by Mass High Tech: The Journal of New England Technology | News | Comments

AesRx LLC, a sickle cell disease-focused biotech firm in Newton, is working with the National Institutes of Health to bring its treatment, Aes-103, designated an orphan drug by the FDA, to clinical trials.

New insight into dementia pathophysiology

November 17, 2010 8:38 am | by EurekAlert | News | Comments

(Cell Press) New research unravels a key molecular pathway underlying a neurodegenerative disorder that causes a devastating type of dementia. The study, published by Cell Press in the November 18 issue of the journal Neuron, sheds light on the pathological processing of...

TOPICS:

Reportlinker Adds Global Uro-Gynecological Surgical Devices Industry

November 17, 2010 7:37 am | by Bio-Medicine.Org | News | Comments

NEW YORK, Nov. 17, 2010 /- Reportlinker.com announces that a new market research report is available in its catalogue: Global Uro-Gynecological Surgical Devices Industry http://www.reportlinker.com/p092549/Global-Uro-Gynecological-Surgical-Devices-Industry.html This report analyzes the...

TOPICS:

Encision's Active Electrode Monitoring Technology Recommended at Minimally Invasive Gynecology Congress

November 17, 2010 7:36 am | by Bio-Medicine.Org | News | Comments

BOULDER, Colo., Nov. 17, 2010 /- Active electrode monitoring developed and manufactured by Boulder-based Encision Inc. (Pink Sheets: ECIA ), is the only monopolar energy technology proposed as a solution to eliminate visceral burns during Single Port Laparoscopy according to a recent...

TOPICS:

Fast Forward, LLC and Provid Pharmaceuticals Announce Expansion of their Partnership for the Development of PV-267, Provid's Unique MS Drug Candidate

November 17, 2010 7:36 am | by Bio-Medicine.Org | News | Comments

NEW YORK and NORTH BRUNSWICK, N.J., Nov. 17, 2010 /- Provid Pharmaceuticals, Inc , a drug discovery company, and Fast Forward, LLC , the National Multiple Sclerosis Society's subsidiary devoted to bridging the gap between research and drug development, today announced an expansion of...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading